Pravastatin Intervention to Delay Hepatocellular Carcinoma Recurrence
Conditions: Hepatocellular Carcinoma; Liver Cirrhoses Interventions: Drug: Pravastatin Pill; Drug: Placebo Oral Tablet Sponsors: Cedars-Sinai Medical Center; National Institutes of Health (NIH) Recruiting - verified July 2017 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - July 13, 2017 Category: Research Source Type: clinical trials